OmniActive has acquired an 85% stake, and has entered into definitive agreements to acquire the balance stake, in Bangalore-based leading health and nutrition active natural ingredients Indfrag. The acquisition includes all products related to Indfrag’s Food & Nutrition business. This, the company says, is in line with OmniActive’s program to create global partnerships which help expand the portfolio of high quality authenticated ingredients for the dietary supplement and functional food industries.

OmniActive notes that Indfrag has established a significant presence in the international market as a leading supplier of high quality botanical and plant extracts from India and South East Asia for the dietary supplement and nutraceuticals industry. The company specializes in production of well-authenticated and standardized natural extracts with fully validated processes and strong quality standards which meet global industry standards. Indfrag ingredients are found in many leading sports and fitness nutrition products of the world. Indfrag is said to be a world-leader in Garcinia Cambogia, Green Coffee, Valerian and natural Caffeine extracts, and a prime manufacturer of other products such Turmeric, Green Tea, Boswellia, Fenugreek ,Senna, Coleus, Guarana, etc.

“Indfrag is a world leader in several well known botanical extracts which form the core of supplement formulas world-wide. The company holds a leadership position in standardized plant extracts. Further, with their strong footprint at the source, they have developed a library of over 100 botanicals-which provides a strong foundation for launching products that complement OmniActive’s innovation platform in meeting emerging industry and consumer needs,” said Sanjaya Mariwala, Managing Director and CEO of OmniActive Health Technologies Ltd. “By coming together, both companies intend to spearhead industry efforts to bring to our customers fully authenticated and validated extracts that meet the emerging standards of safety, reliability, transparency and traceability.”

Building on what it says is an M&A strategy to grow inorganically, OmniActive has acquired Indfrag by raising funds from various sources including the recent PE investment by Everstone. The company says its strengths lie in its ability to leverage its science and technology to meet the demands of consumers and the rigorous scientific standards of quality for today’s dietary supplement market. In the last 18 months, OmniActive completed 12 human clinical trials in healthy populations across its portfolio of branded ingredients, providing unique, science-based claims to expand consumer offerings.

“Having grown to our current size we have been exploring partnerships and alliances which can help expand the market for our current products, and multiply our capability to bring some exciting new products to the market,” said Philip Samuel, Indfrag’s founder and Managing Director. “With its focused, IP protected and clinically substantiated portfolio of branded ingredients and strong industry linkages, OmniActive is a natural partner.”

Indfrag will operate as an independent business, and OmniActive and Indfrag teams will continue to manage their respective product lines and customers.